Forma Therapeutics Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Forma Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2016
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:113
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Forma Therapeutics Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Forma Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Forma Therapeutics Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Forma Therapeutics Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Forma Therapeutics Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Forma Therapeutics Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Forma Therapeutics Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Forma Therapeutics Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Forma Therapeutics Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Deal reports 7
PARTNERSHIP 9
Partnership – Overview 9
Partnership – Deal reports 10
CAPITAL RAISING 94
Capital Raising – Deal reports 94
APPENDIX 103
Contact Us 103
About MarketLine Financial Deals Database 103
Deal Definition and Methodology 105
About MarketLine 112

List of Tables
Table 1: FORMA Therapeutics Inc partnership volume and value trend (2014-YTD2018)
Table 2: FORMA Therapeutics Inc partnership trend by key deal type (2014-YTD2018)

List of Figures
Figure 1: FORMA Therapeutics Inc partnership volume and value trend (2014-YTD2018)
Figure 2: FORMA Therapeutics Inc partnership trend by key deal type (2014-YTD2018)

★海外企業調査レポート[Forma Therapeutics Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Koninklijke KPN NV (KPN):企業の財務・戦略的SWOT分析
    Koninklijke KPN NV (KPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Yapi ve Kredi Bankasi A.S.:戦略・SWOT・企業財務分析
    Yapi ve Kredi Bankasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Yapi ve Kredi Bankasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ghent University-製薬・医療分野:企業M&A・提携分析
    Summary Ghent University (Ghent) is an educational institution that provides research-based educational programmes and services. The university provides educational services such as international courses, preparatory language courses, programmes for exchange students and language courses, among othe …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析
    Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Maruzen Petrochemical Co Ltd:企業の戦略的SWOT分析
    Maruzen Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Linde AG:企業の戦略・SWOT・財務情報
    Linde AG - Strategy, SWOT and Corporate Finance Report Summary Linde AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Bank of Taiwan:企業の戦略・SWOT・財務分析
    Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Spectrum Brands Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spectrum Brands Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spectrum Brands Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Noerr LLP:企業の戦略的SWOT分析
    Noerr LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • JD Sports Fashion Plc:戦略・SWOT・企業財務分析
    JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report Summary JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CP Kelco:企業の戦略・SWOT・財務情報
    CP Kelco - Strategy, SWOT and Corporate Finance Report Summary CP Kelco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Town Health International Medical Group Ltd (3886):企業の財務・戦略的SWOT分析
    Summary Town Health International Medical Group Ltd (THIMGL), formerly Town Health International Investments Ltd, a subsidiary of Hong Kong Health Check and Medical Diagnostic Group Ltd, is a healthcare service provider. The organization offers medical platform, chain clinics, specialty centres, man …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Garden Fresh Restaurant Corp:企業の戦略・SWOT・財務情報
    Garden Fresh Restaurant Corp - Strategy, SWOT and Corporate Finance Report Summary Garden Fresh Restaurant Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SymBio Pharmaceuticals Ltd (4582):企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • Charter Communications, Inc.:戦略・SWOT・企業財務分析
    Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆